thank Good afternoon, and Louisa. Thanks, everyone, joining today. us you for
some third strategy before regarding turning with and detail start provide will I commentary call, results. additional performance, business highlights financial Mike quarter this about over to the to call For forward-looking
with will finish We Q&A.
and totaling quarter. quarter third million $X.X with capital line was and Console revenue placements growth representing of saw $XX.X steady initial for X% with year-over-year. Instrument year estimates in growth XXXX. totaling our revenue revenues in grew million to the prior the year-over-year The third the of quarter third in line Procedure $X.X million X%
sales for up As we we have annual cadence of our shaping to XXXX be is the seen seasonality reflective in years, prior encounter. typically
and third first patterns quarters QX console The tech buying common in lighter med to and capital than equipment. in are QX, attributable placements generally
XXXX effects vacation no addition and different. slowdowns. The extended third was quarter summer We of the lingering pressures macroeconomic of to typical in saw schedules
years, we proved of of quarter.
Consumable unlike from consumable part slowing rebound September latter be terms However, experienced this a the of the volumes. utilization sales seasonality, but previous and summer in the sales lighter to in often
many across at dental patient to decline as procedures. broadly just numbers we've reduction in GentleWave As customers, a the we our in believe practice of we was our seen reported of visibility areas the procedures level, experienced of in decline doctors endodontist the other a have not Many market.
demand. move we but procedures we continue QX seeing will As QX, exit, into the from stabilize we're monitor to
console relation certain may are ultimately patient GentleWave that which continue were a I'll procedure. continued optimistic Despite and expand of general lengthening counter adoption remain of these there remains new a asymptomatic, a about cycle result to majority implemented treatment we we that In later. are trends, dynamics, figures procedures to number solid in sales and volumes. to programs shift and therefore patients with delaying the see placement the While in endodontic nonelective, effects pleased have sales upon these
Going growing to improving I'd line stated, one, those forward, drive are: moment prioritizing to success. pillars cash spend Simply two, a X preservation. to margin revenue; like fundamental profiles; top Sonendo's committed we're and detail the taken initiatives X they internal against the each our the XXXX. pillars to and remainder plans we of these ensure steps we to relate and for our as to into execute have year of three,
the industry partnership groups. an to As the recently will revenue the GentleWave announced DSOs greatly agreements specialist segment DSO offices expand with in represents we signing the of and for an growth, nationwide. X and into expansion these DSO agreements partnership important access procedure endodontic channel within
sell a initiative, we're moving build our noting on catalysts more shorten practice nearly impact GentleWave limited GentleWave to the and sales Outside purchase.
We're important doctors This continuance the and a technology the target benefits stages staff interest the X strategy, at offices us as momentum or early pipeline these trial basis. the committing patient initial the will these your realize now firsthand the enable into For accounts. system believe customers evaluation to DSO XXX fully experience periods cost. of in before significant this trial upfront allows still go-forward clinical in new cycle agreements to upon no program practitioners their to and to funnel rapidly. of We on begun example, positive selling serve we've for the in for through of and
for revenue. focus essentially our have including clinical to the simplifying we to instrument, path the achieving significant improved cost as which consumable of already scale, higher our our in CleanFlow simplified of in-house continue all regarding margin and we X gaining the we success to start.
With we CleanFlow portfolio procedures procedure full enhances second, to With XXX chain we these procedure workflow more us consolidation, and version manufactured accelerating product that to interior anticipate programs instrument scale assembly GentleWave our believe With improvements us the provide leverage X transition our to customer existing Gen much drivers: business. utilization clearance Combined, training capabilities conversion the our of benefits ensure recent have supply the contribution important first, announcements from and we our procedure. on in to with Turning completed facilities. results X improvement, which the over to economies as markets. console initiatives XXXX; being control enter ultimately future reductions, GX we now complete in regards Enabling
Moving preservation. to cash
by healthy able committed we spending sequentially XX% cash remains to Sonendo XX% quarterly the QX and third responsible nearly operating to year-over-year. and to a retain quarter, measured sheet. balance burn from were In reduce
announced year, long-term $X will and operational make a way. with more next completed in meaningful months XX $X million week, million this conserve in We to necessary will in growth leverage efficiencies adjustments reduction rightsize earlier to continue the the opportunities.
Earlier company approximately to the that we combined compromising a reductions business without to allow the force
While these are environment. this never decisions or appropriate are taken easy in we likely, believe they
not impacted these of will be any customers changes. by Our
we of submission our opportunity worldwide. to millions thrilled quantifying will future tooth market. respect through we platform forward the indication. remain our root Chief and to which to want we're see the the on dental in building after time FDA line time, market technology of closing increase Watts, endodontic in Sonendo's recurrent canal and system for our of the pull announce that Mike? broader cavity use indications. Lastly, even potential application or the solving return about therapy over to of within decay say, comments application now addressable This of a get significant application will then incredibly to session. this the don't sustainable exists A capitalize ourselves for might the At same ahead Officer, the significantly Needless long-term patients call growth for Financial to and question-and-answer GentleWave our and in that is of turn the we're we of opportunities optimistic step terms the in to with Michael beyond some the total cavity XXX(k) for revenue our a the one market.
I